PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of bioldirectBioMed CentralBiomed Central Web Sitesearchsubmit a manuscriptregisterthis articleBiology DirectJournal Front Page
 
Biol Direct. 2010; 5: 57.
Published online 2010 October 6. doi:  10.1186/1745-6150-5-57
PMCID: PMC2964539

The origin of Eastern European Jews revealed by autosomal, sex chromosomal and mtDNA polymorphisms

Abstract

Background

This study aims to establish the likely origin of EEJ (Eastern European Jews) by genetic distance analysis of autosomal markers and haplogroups on the X and Y chromosomes and mtDNA.

Results

According to the autosomal polymorphisms the investigated Jewish populations do not share a common origin, and EEJ are closer to Italians in particular and to Europeans in general than to the other Jewish populations. The similarity of EEJ to Italians and Europeans is also supported by the X chromosomal haplogroups. In contrast according to the Y-chromosomal haplogroups EEJ are closest to the non-Jewish populations of the Eastern Mediterranean. MtDNA shows a mixed pattern, but overall EEJ are more distant from most populations and hold a marginal rather than a central position. The autosomal genetic distance matrix has a very high correlation (0.789) with geography, whereas the X-chromosomal, Y-chromosomal and mtDNA matrices have a lower correlation (0.540, 0.395 and 0.641 respectively).

Conclusions

The close genetic resemblance to Italians accords with the historical presumption that Ashkenazi Jews started their migrations across Europe in Italy and with historical evidence that conversion to Judaism was common in ancient Rome. The reasons for the discrepancy between the biparental markers and the uniparental markers are discussed.

Reviewers

This article was reviewed by Damian Labuda (nominated by Jerzy Jurka), Kateryna Makova and Qasim Ayub (nominated by Dan Graur).

Background

The genetic affinities of the Jewish populations have been studied since the early days of genetics, yet the origin of these populations is still obscure. Some of the studies, trying to establish the origins of the Jewish populations with autosomal markers, claimed that the Jewish populations have a common origin, but others concluded that the Jews are a very diverse group. This corpus of studies has already been critically reviewed [1].

The origin of Eastern European Jews, (EEJ) by far the largest and most important Ashkenazi population, and their affinities to other Jewish and European populations are still not resolved. Studies that compared them by genetic distance analysis of autosomal markers to European Mediterranean populations revealed that they are closer to Europeans than to other Jewish populations [1-3].

EEJ are the largest and most investigated Jewish community, yet their history as Franco-German Jewry is known to us only since their appearance in the 9th century, and their subsequent migration a few hundred years later to Eastern Europe [4,5]. Where did these Jews come from? It seems that they came to Germany and France from Italy [5-8]. It is also possible that some Jews migrated northward from the Italian colonies on the northern shore of the Black Sea [9]. All these Jews are likely the descendents of proselytes. Conversion to Judaism was common in Rome in the first centuries BC and AD. Judaism gained many followers among all ranks of Roman Society [10-13].

The aim of this study is to establish the likely origin of this major Jewish population by using a larger dataset of autosomal markers, and compare the results to analyses based on the available data for the X and Y chromosomes and for mtDNA.

Methods

Six Jewish populations: EEJ, Moroccan Jews, Iraqi Jews. Iranian Jews, Yemenite Jews and Ethiopian Jews, which have been studied for all the autosomal markers used in this study, are included in the analysis. EEJ are defined on the basis of history as those Jews originating from the areas of the Polish-Lithuanian Kingdom and their descendants in bordering regions, encompassing the territories of Russia, Poland, the Baltic States, Belarus, Moldavia, Moldova (the north-eastern part of Romania) and the Ukraine. The Data on the non-autosomal markers were also available for other Jewish populations: Bulgarian Jews (X, mtDNA), Turkish Jews (X, mtDNA), Tunisian Jews (mtDNA), Libyan Jews (Y, mtDNA) and Djerban Jews (Y).

The seventeen autosomal markers are: AK, ADA, PGM1, PGD, ACP, ESD, GPT, HP, GC, J311 MspI & MetH TaqI (both on chromosome 7 near the CF locus), FV G1691A, FII G20210A, MTHFR C677T, CBS 844ins68, ACE ID and PAH XmnI. All the markers are unique-event-polymorphisms, and apart from two insertions (CBS 844ins68, ACE ID) are all SNPs. The first nine markers are polymorphisms of red cell enzymes and serum proteins, and were typed mostly by protein electrophoresis, but the variation at the protein level is directly related in a 1:1 manner to the SNP variation at the DNA level. Indeed, some of the results for the Jewish populations were obtained by PCR methods [1,14]. The polymorphism of the remaining eight markers can only be detected at the DNA level. J311 MspI and MetH TaqI were typed in all the populations including the Israeli populations (unpublished results) by Southern blotting and hybridization [15,16]. The other 6 markers were typed in the Israeli populations by PCR methods. The data on FV G1691A, FII G20210A, MTHFR C677T and CBS 844ins68 have already been published [3,17]. The data on ACE ID and PAH XmnI are still unpublished. These polymorphisms were typed according to the methods of Rigat et al. [18] and Goltsov et al. [19] respectively. Allele frequencies for all the populations are given in Additional file 1: tables S1-4. Table S2 (Additional file 1) presents four markers on both sides of the CF locus. Because of the linkage between them, I chose to use only the two most distal markers, which are separated by a few centimorgans. Haplogroup frequencies of the non-recombining Y chromosome (NRY), the X chromosome (dystrophin locus, dys44, on Xp21.3) and mtDNA are given in Additional file 1: tables S5, S6 and S7 respectively.

Gower (cited in [20]) recommends, that for microevolutionary studies, when sample sizes are quite variable and gene frequencies do not differ greatly, Sanghvi's G2 [21] would be the most appropriate, and this is the measure I used. Distances were also calculated with Nei's [22] formula and the results were very similar (r = 0.990, genetic distance matrix not shown). The neighbor joining tree was computed by PHYLIP 3.66. Since it does not calculate Sanghvi's G2, I used Reynolds et al. distance [23], which is also based on the assumption that gene frequencies change by genetic drift alone, solely for the calculation of the tree (genetic distance matrix not shown). The significance of nodes in the tree and the standard errors of the genetic distances were computed by bootstrapping 10,000 times. Multidimensional scaling plots and Mantel tests for correlation between genetic distance matrices and between them and matrices of geographic distances were computed by NTSYS 1.70. Geographic distances were calculated as great circle distances between the capitals of the countries of origin of the populations (Warsaw was chosen for EEJ). Mantel test significance was assessed by 10,000 permutations.

Results

The autosomal genetic distances (table (table1)1) do not show any particular resemblance between the Jewish populations. EEJ are closer to Italians in particular and to Europeans in general than to the other Jewish populations. All of the distances, apart from one, differ from zero by more than twice their standard error. A difference between two distances can be considered meaningful, if it is more than twice their largest standard error. The differences between the distance of EEJ from Italians and their distances from the other Jewish populations are meaningful according to this criterion, and the same is also true for all the Non-Jewish populations except for Greeks and Russians. In fact the distance between EEJ and Italians is the smallest distance in the matrix. A multidimensional scaling plot of the genetic distance matrix (figure (figure1)1) captures the proximity of EEJ to Italians and other European populations. The same is also true for the neighbor joining tree (figure (figure2).2). It should be noted that multidimensional scaling plots are a way to present graphically the intricate relationships of genetic distance matrices. As such they are necessarily less accurate than the matrices on which they are based. In order to understand the genetic affinities of a particular population, one must examine its distances in the matrix itself, not in the plot. The same also applies to the neighbor joining tree. The bootstrap values indicate the robustness of the clustering, but not the significance of individual genetic distances.

Table 1
Autosomal genetic distance matrix (×1000) (standard errors above the diagonal)
Figure 1
A multidimensional scaling plot of the autosomal genetic distance matrix excluding Ethiopian Jews. Stress = 0.100. Populations names are: EEJ - Eastern European Jews, IqJ - Iraqi Jews, InJ - Iranian Jews, MJ - Moroccan Jews, YJ - Yemenite Jews, Pa - Palestinians, ...
Figure 2
A neighbor joining tree based on the autosomal polymorphisms. A number next to a node indicates the majority bootstrap support for that node out of 10,000 repetitions.

X-chromosomal haplogroups demonstrate the same relatedness of EEJ to Italians and other Europeans (table (table2,2, figure figure3).3). In contrast, according to the Y-chromosomal haplogroups EEJ are closest to the non-Jewish populations of the Eastern Mediterranean (table (table3,3, figure figure4).4). MtDNA shows a mixed pattern where EEJ are about equally close to Moroccan Jews, Palestinians, Italians and Bulgarian Jews, but overall are more distant from most populations and hold a marginal position in the MDS plot, rather than a central one like in the other plots (table (table4,4, figure figure55).

Table 2
X chromosomal genetic distance matrix (×1000)
Figure 3
A multidimensional scaling plot of the X-chromosomal genetic distance matrix. Stress = 0.125. Populations names are: EEJ - Eastern European Jews, IqJ - Iraqi Jews, InJ - Iranian Jews, MJ - Moroccan Jews, YJ - Yemenite Jews, EJ - Ethiopian Jews, BJ - Bulgarian ...
Table 3
Y chromosomal genetic distance matrix (×1000)*
Figure 4
A multidimensional scaling plot of the Y-chromosomal genetic distance matrix. Stress = 0.133. Populations names are: EEJ - Eastern European Jews, IqJ - Iraqi Jews, InJ - Iranian Jews, MJ - Moroccan Jews, LJ - Libyan Jews, DJ - Djerban Jews, YJ - Yemenite ...
Table 4
mtDNA genetic distance matrix (×1000)*
Figure 5
A multidimensional scaling plot of the mtDNA genetic distance matrix. Stress = 0.110 for the outer plot and 0.161 for the inner one. Populations names are: EEJ - Eastern European Jews, IqJ - Iraqi Jews, InJ - Iranian Jews, MJ - Moroccan Jews, LJ - Libyan ...

Correlations between genetic distance and geography and between genetic distance matrices based on different markers (excluding the non-Caucasoid populations Ethiopians and Ethiopian Jews) are shown in table table5.5. The autosomal polymorphisms have a very high correlation (0.789) with geography in contrast to the more moderate correlations of the X-chromosomal, Y-chromosomal and mtDNA polymorphisms (0.540, 0.395 and 0.641 respectively). In order to compare two competing theories regarding the origin of EEJ, their geographic distances were computed as if they originated from Italy or Israel, i.e. the great circle distances for EEJ were calculated not between Warsaw and other capitals, but between Rome or Jerusalem and other capitals. The correlation between the autosomal genetic distance matrix and geography was slightly higher, 0.804, for Rome but dropped to 0.694 for Jerusalem. Autosomal distances are much better correlated with mtDNA distances (0.826) and with X-chromosomal distances (0.732) than with Y-chromosomal distances (0.437). The correlations between the mtDNA and X-chromosomal matrices and the Y-chromosomal matrix are rather poor (0.206 and 0.241 respectively) and insignificant. When the correlations with geography were only calculated for the genetic distances of EEJ and not for the entire matrix (table (table6),6), the same trends emerge with the autosomal correlation from Rome reaching a high of 0.926. The correlations from Jerusalem are negative for the autosomes, the X chromosome and mtDNA. The reverse is true for the Y chromosome.

Table 5
Correlation and significance level between genetic distance matrices and between genetic distance and geography
Table 6
Correlation between the genetic distances of EEJ and geography*

Discussion

The autosomal genetic distance analysis presented here clearly demonstrates that the investigated Jewish populations do not share a common origin. The resemblance of EEJ to Italians and other European populations portrays them as an autochthonous European population. A study conducted in a New York college in the 1920s point to the same Ashkenazi - Italian similarity on basis of physical characteristics. Freshmen were asked before they knew one another to indicate the origin of their fellow students. Forty percent of the Italians were taken to be Ashkenazi Jews, and the same percentage of Ashkenazi Jews was adjudged Italians [24]. EEJ seem to be mainly Italian (Roman) in origin, which is easily understood, considering the historical evidence presented above.

The high correlation between the autosomal genetic distances and geography and the reduced correlation when EEJ are taken to originate from the Land of Israel reinforce the European origin of EEJ. In fact the correlation of the autosomal markers with geography is higher than previously described for 49 classical markers (0.503) or ~300,000 autosomal SNPs (0.661) in Europe [25]. If for comparison, only non-Jewish European populations are included, the correlation is lower, 0.689, but still higher than the above mentioned correlations. It is also interesting to note how using the three geographic alternatives for EEJ, changes the correlation, when only European populations are included. The correlation remains almost the same, 0.679, for Rome but drops to 0.490 and 0.571 for Warsaw and Jerusalem respectively; further emphasizing the correct geographic origin of EEJ within Europe.

Biparental versus uniparental markers

At first sight it seems that there is more than one explanation for the differing results produced by the analysis of the NRY haplogroups. It thus seems possible that EEJ founder population in Rome was composed of exiled Israelite males and local Roman females. In its simple form this clearly contradicts the facts, because both the autosomal and X-chromosomal polymorphisms demonstrate that EEJ do not occupy an intermediate position between European and Middle Eastern populations, but rather a strict European one. From table table11 it is clear that Italians are as close or closer to the other Jewish populations and Palestinians as EEJ. It is possible that once the founder population was established no other males but many females joined it, thus creating a population that is almost entirely European in all genetic aspects apart from its Y chromosomes. Such phenomenon was described for the population of Antioquia, Columbia, where the autosomes point to 79% of European ancestry and only 16% of Amerindian ancestry, whereas according to mtDNA the ancestry is 90% Amerindian and only 2% European (there is also a small African component). Historical records demonstrate that local Amerindian females joined the population only at its beginning, whereas European males joined it also in later periods [26]. The suggestion that the proselyte ancestors of EEJ were almost entirely females does not however accord with what we know about conversion to Judaism [10,12,27-29].

The inference that the NRY points to a Middle Eastern origin of EEJ is erroneous not only because the Y chromosomal analysis contradicts the analyses based on the other chromosomes, and because the NRY is a single uniparental marker that does not represent the whole history of the population, but also because its smaller effective population size makes it much more vulnerable to severe genetic drift caused by demographic bottlenecks. The demographic histories of three Jewish populations exemplify how different demographic patterns make the uniparental markers more reliable for Iraqi (Babylonian) Jews and Yemenite Jews and less reliable for EEJ. Both Yemenite Jews and Iraqi Jews resemble populations from their regions of origin according to autosomal markers [1,3,30-32]. Yemenite Jews, who are usually considered a small isolate, were numerous enough to have an independent kingdom in the first centuries AD [33]. They numbered a few hundred thousand in the 12th century AD, and gradually declined; reaching only about 30-40,000 in the beginning of the 20th century [34]. Babylonian Jews numbered more than a million in the first century AD [35], and constituted the majority of the population in the area between the Euphrates and the Tigris in the 2nd-3rd centuries AD [36]. Gilbert [37] estimates that by 600 AD there were 806,000 Jews in Mesopotamia, and according to Sassoon [38] it was inhabited by about a million Jews in the 7th century. In the 14th century the estimates for Baghdad alone range from 70,000 to hundreds thousands [38]. By 1939, 11 years before their emigration, there were 91,000 Jews in Iraq [35]. In contrast, the Jewish population of the Polish-Lithuanian Kingdom (EEJ) went through the opposite process. Their history is one of founder effects, migrations, demographic bottlenecks and finally a rapid expansion. We know nothing about their number in the first millennium, but after their emigration from Italy to Western Europe it is estimated that they numbered 4,000 in 1000 and 20,000 a hundred years later [8]. In 1500 already in Eastern Europe they numbered 10,000-30,000, in 1648 230,000-450,000 and in 1764 750,000 [39-41]. In the 19th century because of the partitions of the Polish-Lithuanian Kingdom and the immigrations of Jews to Central and Western Europe and America, the estimation of the number of EEJ becomes more difficult, but there is no doubt that the increase in numbers was impressive, as the number of EEJ under Russian rule alone was 5,200,000 in 1897 [41].

The existence of severe demographic bottlenecks in the history of EEJ has also been suggested by genetic studies of disease-causing-mutations and mtDNA [42-46]. The comparison based on this second uniparental marker, mtDNA, may help to resolve from within genetics itself the problem of the Y chromosome reliability for inferring the origin of the male ancestors of EEJ. If the European and Middle Eastern contributions to the gene pool of EEJ were female and male respectively, then comparisons based on mtDNA must place EEJ among other European populations, distant from Middle Eastern populations. The mtDNA analysis presented in this study does not place EEJ among other European populations rather their position is more intermediate and marginal, as can be seen in figure figure55 and in figure figure6,6, where autosomal distances are correlated with mtDNA distances. This lends further support to the notion that because of the unique demographic history of EEJ, their uniparental markers were subjected to stronger genetic drift than the biparental markers and thus should not be used to trace their origin.

Figure 6
Correlation of autosomal (X axis) and mtDNA (Y axis) distances. Red circles denote EEJ. Most of the mtDNA distances of EEJ are too high relative to their autosomal distances, in contrast to most other distances (r = 0.826), attesting the greater genetic ...

The data on the Y chromosome itself also support the unreliability of the uniparental markers for discovering the origin of EEJ. Nebel et al. [47] studied haplogroup R-M17, whose frequency is ~12% in Ashkenazi Jews. By comparing the structure of the STRs network among the various Ashkenazi populations and among the various European non-Jewish populations they reached the conclusion that a single male founder introduced this haplogroup into Ashkenazi Jews in the first millennium. Behar et al. [48] write "It is striking that whereas Ashkenazi populations are genetically more diverse at both the SNP and STR level compared with their European non-Jewish counterparts, they have greatly reduced within-haplogroup STR variability ... This contrasting pattern of diversity in Ashkenazi populations is evidence for a reduction in male effective population size, possibly resulting from a series of founder events and high rates of endogamy within Europe. This reduced effective population size may explain the high incidence of founder disease mutations despite overall high levels of NRY diversity". It is unlikely that EEJ are the descendants of a single population. Admixture coupled with small effective population size and bottlenecks can create the puzzling situation we encounter in the uniparental markers. Thus smaller contributions from several populations, including possibly the original Middle Eastern Jewish population, and a major contribution from Italy combined with the unique demography of EEJ can create the current genetic picture without the need to invoke a major contribution from the Middle East, which contradicts the autosomal and X-chromosomal data.

Comments on previous studies

Some previous studies based on classical autosomal markers concluded that EEJ are a Middle Eastern population with genetic affinities to other Jewish populations. The problems with these studies have been previously discussed in detail [1]. These studies used fewer markers (mostly the less reliable antigenic markers) and failed to include European Mediterranean populations, apart from the discriminant analysis of Carmelli and Cavalli-Sforza [49], which used only four markers and contradicts the results of the later more elaborate discriminant analysis [1], and the genetic distance analysis of Livshits et al. [32], which includes a single European Mediterranean population, Spain. Despite this when a genetic distance analysis was performed, the greater similarity of EEJ to Russians and to a lesser extent to Germans more than to Non-European Jews was evident [32]. In fact Russians were more similar to EEJ than to any Non-Jewish European population in that analysis.

Recently, Cochran et al. [50] used 251 autosomal loci to calculate genetic distances and concluded that "from the perspective of a large collection of largely neutral genetic variation Ashkenazim are essentially European, not Middle Eastern". More recently, thousands of SNPs were used by Need et al. [51] to infer the relationships between Ashkenazi Jews and non-Jewish Europeans and Middle Easterners. They concluded that Ashkenazi Jews lie approximately midway between Europeans and the Middle Easterners, implying that Ashkenazi Jews may contain mixed ancestry from these two regions, and that they are close to the Adygei population from the Caucasus. However these conclusions are ill-founded, because, they used a highly selected set of SNPs, which were selected specifically for the purpose of distinguishing between Ashkenazi Jews and other populations and they inferred the origin of Ashkenazi Jews from principal components analysis (PCA), but as Tian et al. [52] show "PCA results are highly dependent on which population groups are included in the analysis. Thus, there should be some caution in interpreting these results and other results from similar analytic methods with respect to ascribing origins of particular ethnic groups'" Tian et al. [52] also published a table of paired Fst distances based on 10,500 random SNPs, which demonstrates that Ashkenazi Jews are not at all close to the Adygei population, and similarly to what is seen in table table1,1, their smallest distance is to Italians and then to Greeks. Unlike the assertion of Need et al. [51] on the midway position, and again similarly to what is seen in table table1,1, Italians and Greeks are closer to the Middle Eastern populations than Ashkenazi Jews.

The same phenomenon is seen in the table of Fst distances of Atzmon et al. [53]. North Italians (Bergamo and Tuscany) are a little closer to the Jewish and Middle Eastern populations than Ashkenazi Jews. The Italians from Tuscany (surprisingly the sample from Bergamo was not used) in Behar et al. [54] are also closer to the Jewish and Middle Eastern populations than Ashkenazi Jews. The Italians from Tuscany are in fact the closest population to Ashkenazi Jews in Behar et al. [54]. There is one sample that is apparently a little closer, what they call Sephardic Jews. Unfortunately this sample is composed of two populations, Turkish Jews and Bulgarian Jews, which should have been studied separately like all other Jewish populations. Bulgarian Jews have been shown in the past based on autosomal classical markers to be closer to EEJ than to populations with Sephardic ancestry and considering their history it was concluded that the Ashkenazi component in their gene pool is at least as large or even larger that the Sephardic component [1]. From both The current study and those of Atzmon et al. [53] and Behar et al. [54] it can be seen that the only Jewish populations that are as close to Ashkenazi Jews as non-Jewish Europeans are those with a significant Sephardic (The descendants of the Jews who were expelled from the Iberian peninsula at the end of the 15th century) component in their gene pool. It is not possible at this stage to say what is the source of this resemblance, since we don't know what is the origin of Sephardic Jews, but considering all the genetic affinities of both groups it likely stems from Sephardic Jews being the descendants of converts in the Mediterranean basin rather than from a common Jewish origin in the Land of Israel. When one compares the autosomal distances of EEJ (current study) or Ashkenazi Jews (in Atzmon et al. [53] and Behar et al. [54]) from the Jewish populations that were investigated in the current study, Iraqi, Iranian, Moroccan, Yemenite and Ethiopian Jews, one finds perfect agreement. EEJ or Ashkenazi Jews are much closer to non-Jewish Europeans than to these Jewish populations in all three studies.

The studies of Atzmon et al. [53] and Behar et al. [54] are based on 164,894 and 226,839 SNPs respectively. While this impressive number reduces the errors of the distances that stem from the number of markers, the errors that stem from sampling only a small number of individuals are much larger in these studies, where sample sizes can be as small as 2-4 individuals. The effect of these errors can be seen in table table7.7. Despite the small number of markers the current matrix has the highest correlation with geography. Moreover it has a higher correlation with each of the two other matrices than the two of them have with each other. The high correlations between the current matrix and the other two attest for the robustness of the autosomal genetic distances in this study. The lower correlation between the two matrices, which are based on more than 150,000 SNPs, is surprising and even more so, if we remember that the four non-Jewish populations are represented by exactly the same individuals taken from the Human Genome Diversity Panel (HGDP). It is likely then that sampling more individuals, which represent more of the variation of the investigated populations, is far more important than typing many markers. It is also possible that the typing error rates of genome-wide microarray studies are much higher, as demonstrated by the genotyping errors that were discovered in 7 out of 29 (24%) reexamined SNPs [55]. It seems therefore, that good characterization of the genetic relationships between populations can be achieved by a small number of good unique-event-polymorphisms.

Table 7
Comparison of the correlations of the three autosomal genetic distance matrices*

Conclusions

EEJ are Europeans probably of Roman descent who converted to Judaism at times, when Judaism was the first monotheistic religion that spread in the ancient world. Any other theory about their origin is not supported by the genetic data. Future studies will have to address their genetic affinities to various Italian populations and examine the possibility of other components both European and Non-European in their gene pool.

Competing interests

The author declares that he has no competing interests.

Reviewers' comments

Reviewer's report 1

Damian Labuda, Pediatrics Department, Montreal University Sainte-Justine Hospital Research Center, Montreal, PQ Canada (nominated by Jerzy Jurka, Genetic Information Research Institute, Mountain View, California USA).

The author compiled and reanalyzed the data on autosomal and sex chromosomes polymorphisms collected by different laboratories on different Jewish and West-Eurasiatic populations. His analysis indicates much greater European component of Eastern European Jews, EEJ (essentially Ashkenazim) than of other Jewish groups. Moreover the analysis points to Italians as the closest population to EEJ.

The question is how to interpret this evidence. Imperial Rome was a very cosmopolitan city culturally and genetically diverse. To what extent a sample of contemporary Italians preserves the genetic link to its population? It can simply reflect a mixture of historical influences from different centers around the Mediterranean Sea. We should thus keep in mind that the Italian connection may simply indicate Southern European and Mediterranean links with the latter including Middle Eastern roots.

Interestingly, this analysis that is based on a limited number of markers provided results that are very similar to a paper of Atzmon and colleagues, published five days ago in the American Journal of Human Genetics, and based on the microarray-based genotyping genome of wide distributed markers. I would like the author to comment on this paper in the context of his findings and his thoughts and reflections on the origin of Jewish Diasporas. Should we go back to the single locus analyses, as in the case of uniparentally transmitted markers, but targeting one by one different individual segments of the nuclear genome? Perhaps, in this way we could partition and identify genetic ancestries of different populations, which due to their history of relative isolation, are considered as genetically homogenous.

The author refers to Sangvi's G2 as the most appropriate distance metrics. Could you make it more clear when this metric was used and when that of Reynolds (only to produce a tree?).

Author's response

The historical sources listed above show that conversion to Judaism was common in ancient Rome among all ranks of the Roman society including the imperial families. It is thus unlikely that the original Roman population did not constitute a significant portion of the proselytes. What else can explain the resemblance of EEJ to a general sample of Italians in this study and to more local samples in the two array studies [53,54]? In all three studies the genetic affinities of the Ashkenazim are very similar to the affinities of the Italians, with the Ashkenazim usually being a bit more distant from the other populations, as can be expected from a population that underwent a stronger genetic drift. It is thus unlikely that the Ashkenazim are a mixture of people from different places in the Mediterranean basin, unless current-day Italians themselves not only have absorbed foreign genetic contributions, but actually constitute such a mixture, and this seems unlikely as well. The very high correlation (0.926) between the genetic distances of EEJ and geographic distances, when the latter are calculated from Rome, also supports the origin of EEJ from Italy or its vicinity and not merely from the Mediterranean basin. The similarity to Italians was also evident when several Italian populations from different provinces were included in a comparison based on classical autosomal markers. Most Italian populations were closer to EEJ than all other populations (data not shown).

My comments on the papers by Atzmon et al. [53] and Behar et al. [54] are in the discussion. Studying autosomal haplotypes will indeed contribute to revealing the ancestries of populations, but in order to gain meaningful insights one ought to study at least several loci and ensure that sample sizes are adequate, this may entail more effort than studying single SNPs, and I am not sure that the affinities between the populations are going to be depicted more accurately. I changed the phrasing in Methods to make it clearer that the formula of Reynolds et al. was only used for the calculation of the tree.

Reviewer's report 2

Kateryna Makova, Department of Biology, Penn State University, Pennsylvania USA.

This is an interesting manuscript that presents intriguing results. I have only a few comments:

1. The introduction is very short, while the discussion is lengthy. I suggest moving parts of the Discussion to the Introduction.

2. Some of the statements in the Discussion are too strong. I disagree with statements about "erroneous Y chromosomal genetic distances", "both uniparental markers should not be used to trace their origin", "uniparental markers being unreliable". The author should modify them.

Author's response

I moved the paragraph on the history of EEJ to the Introduction. The current revised version of the paper includes a new comparison based on mtDNA. I maintain that it adds more weight to my assertion that the uniparental markers should not be used to trace the origin of EEJ. In no way did I mean that the uniparental markers are always unreliable; to clarify it I modified the relevant sentence in the discussion. Indeed from the demographic examples that I give in the Discussion, it seems that the uniparental markers can be used to study the origins of Iraqi Jews and Yemenite Jews.

Reviewer's report 3

Qasim Ayub, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK (nominated by Dan Graur, Department of Biology and Biochemistry, University of Houston, Houston, USA).

The paper by Zoossmann-Diskin entitled 'The origin of Eastern European Jews revealed by autosomal and sex chromosomal polymorphisms' explores autosomal and sex chromosomal polymorphisms in six Jewish populations using previously published and additional unpublished data. The author concludes that the Jewish populations examined do not share a common origin and that Eastern European Jews are closer to the Italian population.

My major concern is the choice of markers and populations used in this study. The author has analyzed 17 autosomal loci, including 9 polymorphic protein electrophoretic variants in which the genotype was assumed. Although phenotypes often do correlate with genotypes assuming that they do can lead to erroneous results. Of the remaining 8 it is unclear whether the same samples were genotyped as the sample numbers for each locus vary widely (Supplementary Tables 2-4).

The author also uses Y hapologroup frequencies and shows a multidimensional scaling plot of Y chromosomal genetic distance matrix. However, the supplementary data (Supplementary Table Table5)5) lists an outdated nomenclature for Y haplogroups as the M78 marker is no longer considered part of haplogroup E3b1. It would be more appropriate to list which markers are used to designate the haplogroups to ensure that they are comparable. In addition, the haplogroups that are selected for these analyses do not provide phylogenetic resolution to reliably detect male genetic sub-structure within the Middle East. The omission of recent mtDNA studies (Behar et al., 2008, PLoS One 3:e2062) is surprising as is the use of a single X chromosomal locus (DYS44) to make broad conclusions about genetic relatedness.

Current evidence, supported more recently by two major studies carried out on Jewish populations (Atzmon et al., Am J H Genetics 86:850-859; Behar et al., Nature doi:10.1038) using a much larger dataset clearly demonstrate a common genetic thread linking the diverse Mizrahi, Sephardic and Ashkenazi Jewish populations with the populations from the Levant and Middle East. The Ashkenazi show a European component but this is shared with many Eastern and Southern Europeans populations. These studies contradict the author's conclusion and demonstrate the power of using unbiased markers and host populations in corresponding geographic regions to address issues such as genetic relatedness among Jewish and non-Jewish populations

Author's response

I am not sure what Dr Ayub means by "assumed", but I suspect that he means something like the relationships between phenotype and genotype in certain blood groups, in which one (or more) allele is dominant over the other and the gene frequencies of the alleles have to be inferred from the phenotypes assuming Hardy-Weinberg equilibrium. In such cases there may indeed be errors in the gene frequencies. Protein electrophoretic markers are completely different. Nothing is inferred! As mentioned in Methods all the protein electrophoretic markers in this study represent a SNP at the DNA level. This SNP causes an amino acid change that can be detected at the protein level. Both alleles are directly viewed on the gel in the same way as both alleles of an RFLP are directly viewed on the gel. Gene frequencies are determined in both cases by simple gene counting and the error rate in protein electrophoresis is no greater than in DNA studies. There is no need to type the same samples for all the polymorphisms, because the unit of study is the population, not the individual. One can use polymorphisms typed by different researchers using different samples and combine them to create a genetic profile of each population. Typing all the polymorphisms on the same sample does not add more credibility to the study. Indeed the renowned works that employed classical autosomal markers to portray the genetic affinities of human populations were based on many different samples typed by many different researchers [56,57].

The nomenclature in the Y chromosome supplementary table has been updated. Following the publication of the study by Behar et al. [54] it was possible to add more Jewish populations to the Y chromosome analysis and increase the number of chromosomes for the Jewish populations. This increase has come however at the expense of resolution, because Behar et al. [54] used fewer haplogroups in their analysis. Consequently the number of haplogroups was reduced from 15 in the original version to 14 in this revised version. I would have been happier if the available data on the Jewish populations had enabled greater resolution to reliably detect male genetic sub-structure within the Middle East, but since this work deals with the genetic affinities of EEJ, the current level is sufficient. The work of Behar et al. from 2008 was instrumental in creating the mtDNA matrix as can be seen in table table77 in Additional file 1. There was no need to cite it previously, as it did not contain any genetic distance analysis that could further clarify the origin of EEJ. I am surprised at Dr Ayub's surprise at the use of a single X chromosomal locus. It would have been better to use many X chromosomal loci, but even the use of single loci is advantageous, as I am sure even Dr Ayub would agree regarding the two other single loci that I use, the non-recombining Y chromosome (NRY) and mtDNA.

As written in the Discussion the genetic distance matrices of Atzmon et al. [53] and Behar et al. [54] do not contradict my results, but reinforce them. I completely reject Dr Ayub's claim that the markers or populations I used are biased in anyway, and I let the reader judge, where exactly the bias lies.

Supplementary Material

Additional file 1:

Allele frequencies tables, Tables S1-S7. The file contains seven tables that give the allele frequencies of the employed polymorphisms.

References

  • Zoossmann-Diskin A, Joel A, Liron M, Kerem B, Shohat M, Peleg L. Protein electrophoretic markers in Israel: compilation of data and genetic affinities. Ann Hum Biol. 2002;29:142–175. doi: 10.1080/03014460110058971. [PubMed] [Cross Ref]
  • Bonné-Tamir B, Zoossmann-Diskin A, Teicher A, Oppenheim A, Nevo S. In: Isolation migration and health. Roberts DF, Fujiki N, Torizuka K, editor. Cambridge: Cambridge University Press; 1992. Genetic distance analyses in Israeli groups using classical markers and DNA polymorphisms in the β-globin gene; pp. 87–106.
  • Zoossmann-Diskin A, Gazit E, Peleg L, Shohat M, Turner D. Thrombophilic polymorphisms in Israel. Blood Cells Mol Dis. 2008;41:230–233. doi: 10.1016/j.bcmd.2008.05.004. [PubMed] [Cross Ref]
  • Ankory Z. In: Genetic diseases among Ashkenazi Jews. Goodman RM, Motulsky AG, editor. New York: Raven Press; 1979. Origins and history of Ashkenazi Jewry (8th to 18th century) pp. 19–46.
  • Hendelssmann Y. In: The History of the people of Israel. Shavit S, Shamir I, editor. Givataim, Israel: Massada; 1985. The Jewish centre in Ashkenaz in the 10-13th centuries; pp. 72–73. (in Hebrew)
  • Renan E. Le judaÏsme comme race et comme religion. Paris: Ancienne Maison Michel Lévy Frères; 1883.
  • Ashdy L. In: Encyclopedia of social sciences. Knaani D, editor. Vol. 1. Tel-Aviv: Sifriat-Poalim; 1970. Germany, Jews; pp. 849–862. (in Hebrew)
  • Kriegel M. In: A historical atlas of the Jewish people. Barnavi E, editor. London: Hutchinson; 1992. The beginnings of European Jewry, 500-1096; pp. 78–79.
  • Halpern I. In: The Jews, their history, culture and religion. Finkelstein L, editor. Vol. 1. New York: Harper & Brothers Publishers; 1960. The Jews in Eastern Europe (From Ancient Times until the Partitions of Poland, 1772-1795) pp. 287–319.
  • Rapaport U. PhD thesis. The Hebrew University; 1965. Jewish religious propaganda and proselytism in the period of the second commonwealth. (in Hebrew with an English abstract)
  • Eilat T. MA thesis. Tel-Aviv University; 1979. The Jewish community in pagan Rome from its beginning in times of the republic till Christianity became a recognized religion of the Roman Empire. (in Hebrew with an English abstract)
  • Feldman LH. In: The Diaspora in the Hellenistic-Roman world. Stern M, editor. The Society For The Publication Of The History Of The Jewish People, Israel; 1983. Proselytism and syncretism; pp. 188–207. (in Hebrew)
  • Meroz N. MA thesis. Tel-Aviv University; 1992. Proselytism in the Roman Empire in the first centuries AD. (in Hebrew with an English abstract)
  • Zoossmann-Diskin A, Swinburne S, Shohat M, Peleg L, Gazit E, Turner D. Typing classical polymorphisms by real-time PCR: analysis of the GPT and ALAD protein polymorphisms in the Jewish populations. Am J Hum Biol. 2008;20:490–492. doi: 10.1002/ajhb.20766. [PubMed] [Cross Ref]
  • Wainwright BJ, Scambler PJ, Schmidtke J, Watson EA, Law HY, Farrall M, Cooke HJ, Eiberg H, Williamson R. Localization of cystic fibrosis locus to human chromosome 7cen-q22. Nature. 1985;318:384–385. doi: 10.1038/318384a0. [PubMed] [Cross Ref]
  • White R, Woodward S, Leppert M, O'connell P, Hoff M, Herbst J, Lalouel JM, Dean M, Vande Woude G. A closely linked genetic marker for cystic fibrosis. Nature. 1985;318:382–384. doi: 10.1038/318382a0. [PubMed] [Cross Ref]
  • Zoossmann-Diskin A, Gazit E, Peleg L, Shohat M, Turner D. 844ins68 in the cystathionine beta-synthase gene in Israel and review of its distribution in the world. Anthropol Anz. 2004;62:147–155. [PubMed]
  • Rigat B, Hubert C, Corvol P, Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1) Nucleic Acids Res. 1992;20:1433. doi: 10.1093/nar/20.6.1433-a. [PMC free article] [PubMed] [Cross Ref]
  • Goltsov AA, Eisensmith RC, Woo SL. Detection of the XmnI RFLP at the human PAH locus by PCR. Nucleic Acids Res. 1992;20:927. doi: 10.1093/nar/20.4.927-a. [PMC free article] [PubMed] [Cross Ref]
  • Jorde LB. In: Current developments in anthropological genetics. Mielke JH, Crawford MH, editor. Vol. 1. New York: Plenum Press; 1980. The genetic structure of subdivided human populations; pp. 135–208.
  • Sanghvi LD. Comparison of genetical and morphological methods for a study of biological differences. Am J Phys Anthropol. 1953;11:385–404. doi: 10.1002/ajpa.1330110313. [PubMed] [Cross Ref]
  • Nei M. Genetic distance between populations. American Naturalist. 1972;106:283–292. doi: 10.1086/282771. [Cross Ref]
  • Reynolds J, Weir BS, Cockerham CC. Estimation of the Coancestry Coefficient: Basis for a Short-Term Genetic Distance. Genetics. 1983;105:767–779. [PubMed]
  • Herskovits MJ. In: The Jews, their history, culture and religion. Finkelstein L, editor. Vol. 2. New York: Harper & Brothers Publishers; 1960. Who are the Jews? pp. 1489–1507.
  • Lao O, Lu TT, Nothnagel M, Junge O, Freitag-Wolf S, Caliebe A, Balascakova M, Bertranpetit J, Bindoff LA, Comas D, Holmlund G, Kouvatsi A, Macek M, Mollet I, Parson W, Palo J, Ploski R, Sajantila A, Tagliabracci A, Gether U, Werge T, Rivadeneira F, Hofman A, Uitterlinden AG, Gieger C, Wichmann HE, Ruther A, Schreiber S, Becker C, Nurnberg P, Nelson MR, Krawczak M, Kayser M. Correlation between genetic and geographic structure in Europe. Curr Biol. 2008;18:1241–1248. doi: 10.1016/j.cub.2008.07.049. [PubMed] [Cross Ref]
  • Bedoya G, Montoya P, Garcia J, Soto I, Bourgeois S, Carvajal L, Labuda D, Alvarez V, Ospina J, Hedrick PW, Ruiz-Linares A. Admixture dynamics in Hispanics: a shift in the nuclear genetic ancestry of a South American population isolate. Proc Natl Acad Sci USA. 2006;103:7234–7239. doi: 10.1073/pnas.0508716103. [PubMed] [Cross Ref]
  • Braude WG. Jewish proselyting in the first five centuries of the common era, the age of the Tannaim and Amoraim. Menasha, WI: The George Banta Publishing Company; 1940.
  • Bamberger BJ. Proselytism in the Talmudic period. New York: Ktav Publishing House; 1968.
  • Rosenbloom JR. Conversion to Judaism: from the biblical period to the present. Cincinnati: Hebrew Union College Press; 1978.
  • Bonné-Tamir B. In: Genetic Microdifferentiation in Human and other Animal Populations: Occasional Papers in Anthropology No. 1. Ahuja YN, Neel JV, editor. Delhi: Indian Anthropological Association; 1985. Oriental Jewish communities and their genetic relationships with South-West Asian populations; pp. 153–170.
  • Bonné-Tamir B, Zoossmann-Diskin A, Teicher A. In: Genetic diversity among Jews: Diseases and markers at the DNA level. Bonné-Tamir B, Adam A, editor. New York: Oxford University Press; 1992. Genetic diversity among Jews reexamined: preliminary analyses at the DNA level; pp. 80–94.
  • Livshits G, Sokal RR, Kobyliansky E. Genetic affinities of Jewish populations. Am J Hum Genet. 1991;49:131–146. [PubMed]
  • Ben-Zeev I. The Jews in Arabia. Jerusalem: Achiassaf; 1970. (in Hebrew)
  • Ashdy L. In: Encyclopedia of social sciences. Knaani D, editor. Vol. 5. Tel-Aviv: Sifriat-Poalim; 1970. Yemen, Jews; pp. 853–854. (in Hebrew)
  • Baron SW. In: Encyclopaedia Judaica. Roth C, Wigoder G, editor. Vol. 13. Jerusalem: Keter Publishing House; 1971. Population; pp. 866–903.
  • Grets T. History of the Jews. Hebrew. Tel-Aviv: Izreel Publishing House; 1955.
  • Gilbert M. Jewish history atlas. Hebrew. Jerusalem: Edanim Publishers (By arrangement with Weidenfeld and Nicolson, London); 1980.
  • Sassoon DS. A history of the Jews in Baghdad. Letchworth, Great Britain; 1949.
  • Baron SW. A social and religious history of the Jews. XVI. New York: Columbia University Press; 1976. Poland-Lithuania 1500-1650.
  • Polonsky A. In: The Jews in old Poland, 1000-1795. Polonsky A, Basista J, Link-Lenczowski A, editor. London: IB Tauris & Co Publishers; 1993. Introduction; pp. 1–9.
  • Stampfer S. In: The broken chain, Polish Jewry through the ages. Bartal I, Gutman I, editor. Jerusalem: The Zalman Shazar Center; 1997. Population growth and emmigration of the Polish-Lithuanian Jewry in the 16-19th centuries; pp. 263–285. (in Hebrew)
  • Diaz GA, Gelb BD, Risch N, Nygaard TG, Frisch A, Cohen IJ, Miranda CS, Amaral O, Maire I, Poenaru L, Caillaud C, Weizberg M, Mistry P, Desnick RJ. Gaucher disease: the origins of the Ashkenazi Jewish N370S and 84GG acid beta-glucosidase mutations. Am J Hum Genet. 2000;66:1821–1832. doi: 10.1086/302946. [PubMed] [Cross Ref]
  • Frisch A, Colombo R, Michaelovsky E, Karpati M, Goldman B, Peleg L. Origin and spread of the 1278insTATC mutation causing Tay-Sachs disease in Ashkenazi Jews: genetic drift as a robust and parsimonious hypothesis. Hum Genet. 2004;114:366–376. doi: 10.1007/s00439-003-1072-8. [PubMed] [Cross Ref]
  • Risch N, Tang H, Katzenstein H, Ekstein J. Geographic distribution of disease mutations in the Ashkenazi Jewish population supports genetic drift over selection. Am J Hum Genet. 2003;72:812–822. doi: 10.1086/373882. [PubMed] [Cross Ref]
  • Slatkin M. A population-genetic test of founder effects and implications for Ashkenazi Jewish diseases. Am J Hum Genet. 2004;75:282–293. doi: 10.1086/423146. [PubMed] [Cross Ref]
  • Behar DM, Hammer MF, Garrigan D, Villems R, Bonné-Tamir B, Richards M, Gurwitz D, Rosengarten D, Kaplan M, Della Pergola S, Quintana-Murci L, Skorecki K. MtDNA evidence for a genetic bottleneck in the early history of the Ashkenazi Jewish population. Eur J Hum Genet. 2004;12:355–364. doi: 10.1038/sj.ejhg.5201156. [PubMed] [Cross Ref]
  • Nebel A, Filon D, Faerman M, Soodyall H, Oppenheim A. Y chromosome evidence for a founder effect in Ashkenazi Jews. Eur J Hum Genet. 2005;13:388–391. doi: 10.1038/sj.ejhg.5201319. [PubMed] [Cross Ref]
  • Behar DM, Garrigan D, Kaplan ME, Mobasher Z, Rosengarten D, Karafet TM, Quintana-Murci L, Ostrer H, Skorecki K, Hammer MF. Contrasting patterns of Y chromosome variation in Ashkenazi Jewish and host non-Jewish European populations. Hum Genet. 2004;114:354–365. doi: 10.1007/s00439-003-1073-7. [PubMed] [Cross Ref]
  • Carmelli D, Cavalli-Sforza LL. The genetic origin of the Jews: a multivariate approach. Hum Biol. 1979;51:41–61. [PubMed]
  • Cochran G, Hardy J, Harpending H. Natural history of ashkenazi intelligence. J Biosoc Sci. 2006;38:659–693. doi: 10.1017/S0021932005027069. [PubMed] [Cross Ref]
  • Need AC, Kasperaviciute D, Cirulli ET, Goldstein DB. A genome-wide genetic signature of Jewish ancestry perfectly separates individuals with and without full Jewish ancestry in a large random sample of European Americans. Genome Biol. 2009;10:R7. doi: 10.1186/gb-2009-10-1-r7. [PMC free article] [PubMed] [Cross Ref]
  • Tian C, Kosoy R, Nassir R, Lee A, Villoslada P, Klareskog L, Hammarstrom L, Garchon HJ, Pulver AE, Ransom M, Gregersen PK, Seldin MF. European Population Genetic Substructure: Further Definition of Ancestry Informative Markers for Distinguishing Among Diverse European Ethnic Groups. Mol Med. 2009;15:371–383. doi: 10.2119/molmed.2009.00094. [PMC free article] [PubMed] [Cross Ref]
  • Atzmon G, Hao L, Pe'er I, Velez C, Pearlman A, Palamara PF, Morrow B, Friedman E, Oddoux C, Burns E, Ostrer H. Abraham's children in the genome era: major Jewish diaspora populations comprise distinct genetic clusters with shared Middle Eastern Ancestry. Am J Hum Genet. 2010;86:850–859. doi: 10.1016/j.ajhg.2010.04.015. [PubMed] [Cross Ref]
  • Behar DM, Yunusbayev B, Metspalu M, Metspalu E, Rosset S, Parik J, Rootsi S, Chaubey G, Kutuev I, Yudkovsky G, Khusnutdinova EK, Balanovsky O, Semino O, Pereira L, Comas D, Gurwitz D, Bonne-Tamir B, Parfitt T, Hammer MF, Skorecki K, Villems R. The genome-wide structure of the Jewish people. Nature. 2010;466:238–242. doi: 10.1038/nature09103. [PubMed] [Cross Ref]
  • Xue Y, Zhang X, Huang N, Daly A, Gillson CJ, Macarthur DG, Yngvadottir B, Nica AC, Woodwark C, Chen Y, Conrad DF, Ayub Q, Mehdi SQ, Li P, Tyler-Smith C. Population differentiation as an indicator of recent positive selection in humans: an empirical evaluation. Genetics. 2009;183:1065–1077. doi: 10.1534/genetics.109.107722. [PubMed] [Cross Ref]
  • Cavalli-Sforza LL, Piazza A. Human genomic diversity in Europe: a summary of recent research and prospects for the future. Eur J Hum Genet. 1993;1:3–18. [PubMed]
  • Cavalli-Sforza LL, Menozzi P, Piazza A. The history and geography of human genes. Princeton: Princeton University Press; 1994.
  • Weber W. Untersuchungen von in Deutschland lebenden Türken in 23 Blutgruppensystemen; Bedeutung für die Biostatistik. Das Ärztliche Laboratorium. 1983;29:171–178.
  • Walter H, Gölge M, Aksoy M, Bermik E, Sivasli A. Genetic serum protein markers (HP, GC, TF, PI) in four Turkish population samples. Int J Anthropol. 1992;7:27–32. doi: 10.1007/BF02447867. [Cross Ref]
  • Brega A, Scacchi R, Cuccia M, Kirdar B, Peloso G, Corbo RM. Study of 15 protein polymorphisms in a sample of the Turkish population. Hum Biol. 1998;70:715–728. [PubMed]
  • Tsiakalos G, Walter H, Hilling M, Schaarschmidt L. Investigations on the distribution of genetic polymorphisms in Greece. 2. Serum protein polymorphisms. Anthropol Anz. 1981;39:1–9. [PubMed]
  • Tsiakalos G, Walter H, Hilling M. Investigation on the distribution of genetic polymorphisms in Greece. 3. Red cell enzyme polymorphisms and genetic distances. Anthropol Anz. 1981;39:244–254. [PubMed]
  • Kouvatsi A, Triantaphyllidis CD. Gc and Tf subtypes in Greece. Hum hered. 1987;37:62–64. doi: 10.1159/000153679. [PubMed] [Cross Ref]
  • Hundrieser J, Bremer S, Peinemann F, Stuhrmann M, Hoffknecht N, Wulf B, Schmidtke J, Reiss J, Maass G, Tümmler B. Frequency of the F508 deletion in the CFTR gene in Turkish cystic fibrosis patients. Hum Genet. 1990;85:409–410. doi: 10.1007/BF02428283. [PubMed] [Cross Ref]
  • Devoto M, De Benedetti L, Seia M, Piceni Sereni L, Ferrari M, Bonduelle ML, Malfroot A, Lissens W, Balassopoulou A, Adam G, Loukopoulos D, Cochaux p, Vassart G, Szibor R, Hein J, Grade K, Berger W, Wainwright B, Romeo G. Haplotypes in cystic fibrosis patients with or without pancreatic insufficiency from four European populations. Genomics. 1989;5:894–898. doi: 10.1016/0888-7543(89)90131-6. [PubMed] [Cross Ref]
  • Weber J, Aulehla-Scholz C, Kaiser R, Eigel A, Neugebauer M, Horst J, Olek K. Cystic fibrosis: typing 89 German families with linked DNA probes. Hum Genet. 1988;81:54–56. doi: 10.1007/BF00283729. [PubMed] [Cross Ref]
  • Tummler B, Aschendorff A, Darnedde T, Fryburg K, Maass G, Hundrieser J. Marker haplotype association with growth in German cystic fibrosis patients. Hum Genet. 1990;84:267–273. doi: 10.1007/BF00200573. [PubMed] [Cross Ref]
  • Schmidtke J, Krawczak M, Schwartz M, Alkan M, Bonduelle M, Bühler E, Chemke M, Darnedde T, Domagk J, Engel W, Frey D, Fryborg K, Halley D, Hundrieser J, Ladanyi L, Libaers I, Lissens W, Mächler M, Malik NJ, Morreau J, Neubauer V, Oostra B, Pape B, Poncin JE, Schinzel A, Simon P, Trefz FK, Tümmler B, Vassart G, Voss R. Linkage relationships and allelic associations of the cystic fibrosis locus and four marker loci. Hum Genet. 1987;76:337–343. doi: 10.1007/BF00272441. [PubMed] [Cross Ref]
  • Dean M, Amos JA, Lynch J, Romeo G, Devoto M, Ward K, Halley D, Oostra B, Ferrari M, Russo S, Weir BS, Finn PB, Collins FS, Iannuzzi MC. Prenatal diagnosis and linkage disequilibrium with cystic fibrosis for markers surrounding D7S8. Hum Genet. 1990;85:275–278. doi: 10.1007/BF00206745. [PubMed] [Cross Ref]
  • Beaudet A, Bowcock A, Buchwald M, Cavalli-Sforza L, Farrall M, King MC, Klinger K, Lalouel JM, Lathrop G, Naylor S, Ott J, Tsui LC, Wainwright B, Watkins P, White R, Williamson R. Linkage of cystic fibrosis to two tightly linked DNA markers: joint report from a collaborative study. Am J Hum Genet. 1986;39:681–693. [PubMed]
  • Ramsay M, Williamson R, Estivill X, Wainwright BJ, Ho MF, Halford S, Kere J, Savilahti E, de la Chapelle A, Schwartz M, Super M, Farndon P, Harding C, Meredith L, Al-Jader L, Ferec C, Claustres M, Casais T, Nunes V, Gasparini P, Savoia A, Pignatti PP, Novelli G, Bennarelli M, Dallapicola B, Kalaydjieva L, Scambler PJ:. Haplotype analysis to determine the position of a mutation among closely linked DNA markers. Hum Mol Genet. 1993;2:1007–1014. doi: 10.1093/hmg/2.7.1007. [PubMed] [Cross Ref]
  • Harris A, Beards F, Mathew C. Mutation analysis at the cystic fibrosis locus in the British population. Hum Genet. 1990;85:408–409. doi: 10.1007/BF02428282. [PubMed] [Cross Ref]
  • McIntosh I, Curtis A, Lorenzo ML, Keston M, Gilfillan AJ, Morris G, Brock DJ. The haplotype distribution of the delta F508 mutation in cystic fibrosis families in Scotland. Hum Genet. 1990;85:419–420. doi: 10.1007/BF02428290. [PubMed] [Cross Ref]
  • Mornet E, Simon-Bouy B, Serre JL, Estivill X, Farrall M, Williamson R, Boue J, Boue A. Genetic differences between cystic fibrosis with and without meconium ileus. Lancet. 1988;1:376–378. doi: 10.1016/S0140-6736(88)91180-4. [PubMed] [Cross Ref]
  • Vidaud M, Kitzis A, Ferec C, Bozon D, Dumur V, Giraud G, David F, Pascal O, Auvinet M, Morel Y, Andre J, Chomel JC, Saleun JP, Farriaux JP, Roussel P, Labbé A, Dastugue B, Lucotte G, Monnier N, Foucaud P, goossens M, Feingold J, Kaplan JC. Confirmation of linkage disequilibrium between haplotype B (XV-2c, allele 1;KM-19, allele 2) and cystic fibrosis allele in the French population. Hum Genet. 1989;81:183–184. doi: 10.1007/BF00293899. [PubMed] [Cross Ref]
  • Serre JL, Simon-Bouy B, Mornet E, Jaume-Roig B, Balassopoulou A, Schwartz M, Taillandier A, Boué J, Boué A. Studies of RFLP closely linked to the cystic fibrosis locus throughout Europe lead to new considerations in populations genetics. Hum Genet. 1990;84:449–454. doi: 10.1007/BF00195818. [PubMed] [Cross Ref]
  • Ferec C, Verlingue C, Parent P. Desequilibre de liaison et marqueurs de l'ADN associes au gene de la fibrose kystique. J Genet Hum. 1989;37:407–423. [PubMed]
  • Baranov VS, Ivashchenko TE, Gorbunova VN, Voronina OV, Gaĭtskhoki VS, Gol'tsov AA, Kaboev OK, Shvarts EI, Berlin YuA, Livshits LA, Buzhievskaya TI, Venozhinskis MT, Sokolov BP, Kalinin VN, Orlov AV, Romanenko OP, Luk'yanenko AN, Kapranov NI, Rachinskii SV. Allele polymorphism of the DNA loci MET, D7S8, D7S23, linked to the cystic fibrosis gene in some populations of the USSR, in high risk families and in cystic fibrosis patients. Genetika. 1991;27:113–121. (in Russian) [PubMed]
  • Voronina OV, Baranov VS, Gaitskhoki VS, Gorbunova VN, Ivashchenko TE, Shvartsman AL. Polymorphism of nucleotide sequences of human genomic DNA linked to a mucoviscidosis locus. Mol Gen Mikrobiol Virusol. 1990. pp. 14–17. (in Russian) [PubMed]
  • Bal J, Maciejko D, Buława E, Mazurczak T. Zastosowanie sond molekularnych DNA w diagnostyce mukowiscydozy--analiza polimorfizmu dlugosci fragmentow restrykcyjnych (RFLP) w 22 rodzinach wysokiego ryzyka. Pol Tyg Lek. 1992;47:215–218. [PubMed]
  • Akar N, Akar E, Misirlioğlu M, Avcu F, Yalçin A, Cin S. Search for genetic factors favoring thrombosis in Turkish population. Thromb Res. 1998;92:79–82. doi: 10.1016/S0049-3848(98)00113-3. [PubMed] [Cross Ref]
  • Akar N, Misirlioğlu M, Akar E, Avcu F, Yalçin A, Sözüöz A. Prothrombin gene 20210 G-A mutation in the Turkish population. Am J Hematol. 1998;58:249. doi: 10.1002/(SICI)1096-8652(199807)58:3<249::AID-AJH20>3.0.CO;2-3. [PubMed] [Cross Ref]
  • Balta G, Gürgey A. Methylenetetrahydrofolate reductase (MTHFR) C677T mutation in Turkish patients with thrombosis. Turk J Pediatr. 1999;41:197–199. [PubMed]
  • Gürgey A, Mesci L. The prevalence of factor V Leiden (1691 G-- > A) mutation in Turkey. Turk J Pediatr. 1997;39:313–315. [PubMed]
  • Ozbek U, Tangün Y. Frequency of factor V Leiden (Arg506Gln) in Turkey. Br J Haematol. 1997;97:504–505. doi: 10.1046/j.1365-2141.1997.d01-3343.x. [PubMed] [Cross Ref]
  • Sazci A, Ergul E, Kaya G, Kara I. Genotype and allele frequencies of the polymorphic methylenetetrahydrofolate reductase gene in Turkey. Cell Biochem Funct. 2005;23:51–54. doi: 10.1002/cbf.1132. [PubMed] [Cross Ref]
  • Sehirali S, Inal MM, Yildirim Y, Balim Z, Kosova B, Karamizrak T, Sanci M, Topcuoglu N, Tinar S. Prothrombin G20210A mutation in cases with recurrent miscarriage: a study of the mediterranean population. Arch Gynecol Obstet. 2005;273:170–173. doi: 10.1007/s00404-005-0061-7. [PubMed] [Cross Ref]
  • Antoniadi T, Hatzis T, Kroupis C, Economou-Petersen E, Petersen MB. Prevalence of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations in a Greek population of blood donors. Am J Hematol. 1999;61:265–267. doi: 10.1002/(SICI)1096-8652(199908)61:4<265::AID-AJH8>3.0.CO;2-#. [PubMed] [Cross Ref]
  • Pallaud C, Stranieri C, Sass C, Siest G, Pignatti F, Visvikis S. Candidate gene polymorphisms in cardiovascular disease: a comparative study of frequencies between a French and an Italian population. Clin Chem Lab Med. 2001;39:146–154. doi: 10.1515/CCLM.2001.025. [PubMed] [Cross Ref]
  • Margaglione M, D'Andrea G, Giuliani N, Brancaccio V, De Lucia D, Grandone E, De Stefano V, Tonali PA, Di Minno G. Inherited prothrombotic conditions and premature ischemic stroke: sex difference in the association with factor V Leiden. Arterioscler Thromb Vasc Biol. 1999;19:1751–1756. [PubMed]
  • Rosendaal FR, Doggen CJ, Zivelin A, Arruda VR, Aiach M, Siscovick DS, Hillarp A, Watzke HH, Bernardi F, Cumming AM, Preston FE, Reitsma PH. Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost. 1998;79:706–708. [PubMed]
  • Schwender S, Großmann R, Keller F. High prevalence of factor V Leiden mutation is detected in a north to south axis through Germany. Journal of Laboratory Medicine. 1997;21:347–352.
  • Reuner KH, Ruf A, Grau A, Rickmann H, Stolz E, Jüttler E, Druschky KF, Patscheke H. Prothrombin gene G20210-- > A transition is a risk factor for cerebral venous thrombosis. Stroke. 1998;29:1765–1769. [PubMed]
  • Junker R, Koch HG, Auberger K, Munchow N, Ehrenforth S, Nowak-Gottl U. Prothrombin G20210A gene mutation and further prothrombotic risk factors in childhood thrombophilia. Arterioscler Thromb Vasc Biol. 1999;19:2568–2572. [PubMed]
  • Reuner KH, Ruf A, Kaps M, Druschky KF, Patscheke H. The mutation C677-- > T in the methylene tetrahydrofolate reductase gene and stroke. Thromb Haemost. 1998;79:450–451. [PubMed]
  • O'Shaughnessy KM, Fu B, Ferraro F, Lewis I, Downing S, Morris NH. Factor V Leiden and thermolabile methylenetetrahydrofolate reductase gene variants in an East Anglian preeclampsia cohort. Hypertension. 1999;33:1338–1341. [PubMed]
  • Croft SA, Daly ME, Steeds RP, Channer KS, Samani NJ, Hampton KK. The prothrombin 20210A allele and its association with myocardial infarction. Thromb Haemost. 1999;81:861–864. [PubMed]
  • Morrison ER, Miedzybrodzka ZH, Campbell DM, Haites NE, Wilson BJ, Watson MS, Greaves M, Vickers MA. Prothrombotic genotypes are not associated with pre-eclampsia and gestational hypertension: results from a large population-based study and systematic review. Thromb Haemost. 2002;87:779–785. [PubMed]
  • Schneider JA, Rees DC, Liu YT, Clegg JB. Worldwide distribution of a common methylenetetrahydrofolate reductase mutation. Am J Hum Genet. 1998;62:1258–1260. doi: 10.1086/301836. [PubMed] [Cross Ref]
  • Alhenc-Gelas M, Arnaud E, Nicaud V, Aubry ML, Fiessinger JN, Aiach M, Emmerich J. Venous thromboembolic disease and the prothrombin, methylene tetrahydrofolate reductase and factor V genes. Thromb Haemost. 1999;81:506–510. [PubMed]
  • Harrington DJ, Malefora A, Schmeleva V, Kapustin S, Papayan L, Blinov M, Harrington P, Mitchell M, Savidge GF. Genetic variations observed in arterial and venous thromboembolism -- relevance for therapy, risk prevention and prognosis. Clin Chem Lab Med. 2003;41:496–500. doi: 10.1515/CCLM.2003.075. [PubMed] [Cross Ref]
  • Sawuła W, Banecka-Majkutewicz Z, Kadziński L, Jakóbkiewicz-Banecka J, Wegrzyn G, Nyka W, Banecki B. Homocysteine level and metabolism in ischemic stroke in the population of Northern Poland. Clin Biochem. 2009;42:442–447. doi: 10.1016/j.clinbiochem.2008.12.019. [PubMed] [Cross Ref]
  • Lopaciuk S, Bykowska K, Kwiecinski H, Mickielewicz A, Czlonkowska A, Mendel T, Kuczynska-Zardzewialy A, Szelagowska D, Windyga J, Schröder W, Herrmann FH, Jedrzejowska H. Factor V Leiden, prothrombin gene G20210A variant, and methylenetetrahydrofolate reductase C677T genotype in young adults with ischemic stroke. Clin Appl Thromb Hemost. 2001;7:346–350. doi: 10.1177/107602960100700418. [PubMed] [Cross Ref]
  • Nizankowska-Mogilnicka E, Adamek L, Grzanka P, Domagala TB, Sanak M, Krzanowski M, Szczeklik A. Genetic polymorphisms associated with acute pulmonary embolism and deep venous thrombosis. Eur Respir J. 2003;21:25–30. doi: 10.1183/09031936.03.00034302. [PubMed] [Cross Ref]
  • Szperl M, Dzielinska Z, Roszczynko M, Malek LA, Makowiecka-Ciesla M, Demkow M, Kadziela J, Prejbisz A, Florczak E, Zielinski T, Januszewicz A, Ruzyllo W. Genetic variants in hypertensive patients with coronary artery disease and coexisting atheromatous renal artery stenosis. Med Sci Monit. 2008;14:CR611–616. [PubMed]
  • Akcali C, Ozkur M, Erbagci Z, Benlier N, Aynacioglu AS. Association of insertion/deletion polymorphism of the angiotensin-converting enzyme gene with angio-oedema accompanying chronic urticaria but not chronic urticaria without angio-oedema or the autologous serum skin test response. J Eur Acad Dermatol Venereol. 2008;22:83–86. [PubMed]
  • Comas D, Schmid H, Braeuer S, Flaiz C, Busquets A, Calafell F, Bertranpetit J, Scheil HG, Huckenbeck W, Efremovska L, Schmidt H. Alu insertion polymorphisms in the Balkans and the origins of the Aromuns. Ann Hum Genet. 2004;68:120–127. doi: 10.1046/j.1529-8817.2003.00080.x. [PubMed] [Cross Ref]
  • Lichter-Konecki U, Schlotter M, Yaylak C, Ozgüç M, Coskun T, Ozalp I, Wendel U, Batzler U, Trefz FK, Konecki D. DNA haplotype analysis at the phenylalanine hydroxylase locus in the Turkish population. Hum Genet. 1989;81:373–376. doi: 10.1007/BF00283695. [PubMed] [Cross Ref]
  • Stuhrmann M, Riess O, Monch E, Kurdoglu G. Haplotype analysis of the phenylalanine hydroxylase gene in Turkish phenylketonuria families. Clin Genet. 1989;36:117–121. doi: 10.1111/j.1399-0004.1989.tb03173.x. [PubMed] [Cross Ref]
  • Chen SH, Giblett ER, Anderson JE, Fossum BL. Genetics of glutamic-pyruvic transaminase: its inheritance, common and rare variants, population distribution, and differences in catalytic activity. Ann Hum Genet. 1972;35:401–409. [PubMed]
  • Moran CN, Vassilopoulos C, Tsiokanos A, Jamurtas AZ, Bailey ME, Montgomery HE, Wilson RH, Pitsiladis YP. The associations of ACE polymorphisms with physical, physiological and skill parameters in adolescents. Eur J Hum Genet. 2006;14:332–339. doi: 10.1038/sj.ejhg.5201550. [PubMed] [Cross Ref]
  • Biondi G, Calabro V, Colonna-Romano S, Giangregorio M, Malaspina P, Petrucci R, Santolamazza C, Santolamazza P, Tramontano E, Battistuzzi G. Common and rare genetic variants of human red blood cell enzymes in Italy. Anthropol Anz. 1989;47:155–174. [PubMed]
  • Dianzani I, Devoto M, Camaschella C, Saglio G, Ferrero GB, Cerone R, Romano C, Romeo G, Giovannini M, Riva E, Angeneydt F, Trefz FK, Okano Y, Woo SLC. Haplotype distribution and molecular defects at the phenylalanine hydroxylase locus in Italy. Hum Genet. 1990;86:69–72. doi: 10.1007/BF00205176. [PubMed] [Cross Ref]
  • Santovito A, Selvaggi A, Cervella P, Castellano S, Bigatti MP, Sella G, Delpero M. Polymorphic Alu insertions in five North-West Italian populations. Am J Hum Biol. 2007;19:589–592. doi: 10.1002/ajhb.20605. [PubMed] [Cross Ref]
  • Aulehla-Scholz C, Vorgerd M, Sautter E, Leupold D, Mahlmann R, Ullrich K, Olek K, Horst J. Phenylketonuria: distribution of DNA diagnostic patterns in German families. Hum genet. 1988;78:353–355. doi: 10.1007/BF00291734. [PubMed] [Cross Ref]
  • Herrmann FH, Wulff K, Wehnert M, Seidlitz G, Guttler F. Haplotype analysis of classical and mild phenotype of phenylketonuria in the German Democratic Republic. Clin Genet. 1988;34:176–180. doi: 10.1111/j.1399-0004.1988.tb02859.x. [PubMed] [Cross Ref]
  • Kompf J, Ritter H. Polymorphism of alanine aminotransferase (E.C.2.7.6.1): common and rare alleles. Hum Genet. 1979;51:287–292. [PubMed]
  • Schmidt S, Schone N, Ritz E. Association of ACE gene polymorphism and diabetic nephropathy? The Diabetic Nephropathy Study Group. Kidney Int. 1995;47:1176–1181. doi: 10.1038/ki.1995.167. [PubMed] [Cross Ref]
  • Schunkert H, Hense HW, Holmer SR, Stender M, Perz S, Keil U, Lorell BH, Riegger GA. Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl J Med. 1994;330:1634–1638. doi: 10.1056/NEJM199406093302302. [PubMed] [Cross Ref]
  • Welch SG, Mills PR, Gaensslen RE. Phenotypic distributions of red cell glutamate-pyruvate transaminase (E.C.2.6.1.2) isoenzymes in British and New York populations. Humangenetik. 1975;27:59–62. [PubMed]
  • Narain Y, Yip A, Murphy T, Brayne C, Easton D, Evans JG, Xuereb J, Cairns N, Esiri MM, Furlong RA, Rubinsztein DC. The ACE gene and Alzheimer's disease susceptibility. J Med Genet. 2000;37:695–697. doi: 10.1136/jmg.37.9.695. [PMC free article] [PubMed] [Cross Ref]
  • Sullivan SE, Moore SD, Connor JM, King M, Cockburn F, Steinmann B, Gitzelmann R, Daiger SP, Woo SL. Haplotype distribution of the human phenylalanine hydroxylase locus in Scotland and Switzerland. Am J Hum Genet. 1989;44:652–659. [PubMed]
  • de Bosschere JP, Dinh Khoi T, Quennehen F, Le Treut A, Fauchet R, Le Gall JY. Etude du polymorphisme génétique de quelques enzymes érythrocytaires dans la région de Rennes. Nouv Rev Fr Hematol. 1979;21:9–15. [PubMed]
  • Abadie V, Lyonnet S, Melle D, Berthelon M, Caillaud C, Labrune Ph, Rey F, Rey J, Munnich A. Molecular basis of phenylketonuria in France. Developmental Brain Dysfunction. 1993;6:120–126.
  • Kidd JR, Pakstis AJ, Zhao H, Lu RB, Okonofua FE, Odunsi A, Grigorenko E, Bonné-Tamir B, Friedlaender J, Schulz LO, Parnas J, Kidd KK. Haplotypes and linkage disequilibrium at the phenylalanine hydroxylase locus, PAH, in a global representation of populations. Am J Hum Genet. 2000;66:1882–1899. doi: 10.1086/302952. [PubMed] [Cross Ref]
  • Solovenchuk LL. Polymorphic biochemical systems in the population of immigrant inhabitants of the northeastern USSR. I. The genetic structure and its heterogeneity due to sexual dimorphism and to the duration of separate groups living under extreme environmental conditions. Genetika. 1983;19:1327–1334. (in Russian) [PubMed]
  • Altukhov Iu P, Khil'chevskaia RI, Shurkhal AV. Polymorphism and heterozygosity levels of the Russian population of Moscow: data for 22 gene loci coding blood proteins. Genetika. 1981;17:548–555. (in Russian) [PubMed]
  • Nazarov IB, Woods DR, Montgomery HE, Shneider OV, Kazakov VI, Tomilin NV, Rogozkin VA. The angiotensin converting enzyme I/D polymorphism in Russian athletes. Eur J Hum Genet. 2001;9:797–801. doi: 10.1038/sj.ejhg.5200711. [PubMed] [Cross Ref]
  • Jaruzelska J, Henriksen KF, Guttler F, Riess O, Borski K, Blin N, Slomski R. The codon 408 mutation associated with haplotype 2 is predominant in Polish families with phenylketonuria. Hum Genet. 1991;86:247–250. doi: 10.1007/BF00202402. [PubMed] [Cross Ref]
  • Zygulska M, Eigel A, Aulehla-Scholz C, Pietrzyk JJ, Horst J. Molecular analysis of PKU haplotypes in the population of southern Poland. Hum Genet. 1991;86:292–294. doi: 10.1007/BF00202412. [PubMed] [Cross Ref]
  • Schlesinger D, Dobosz T. GPT polymorphism in the Polish population. Arch Immunol Ther Exp. 1976;24:423–428. [PubMed]
  • Grzeszczak W, Misztalski T. Is insertion/deletion polymorphism angiotensin-converting enzyme gene responsible for long-life? Przegl Lek. 2002;59:79–83. (in Polish) [PubMed]
  • Shen P, Lavi T, Kivisild T, Chou V, Sengun D, Gefel D, Shpirer I, Woolf E, Hillel J, Feldman MW, Oefner PJ. Reconstruction of patrilineages and matrilineages of Samaritans and other Israeli populations from Y-chromosome and mitochondrial DNA sequence variation. Hum Mutat. 2004;24:248–260. doi: 10.1002/humu.20077. [PubMed] [Cross Ref]
  • Capelli C, Redhead N, Romano, Calì F, Lefranc G, Delague V, Megarbane A, Felice AE, Pascali VL, Neophytou PI, Poulli Z, Novelletto A, Malaspina P, Terrenato L, Berebbi A, Fellous M, Thomas MG, Goldstein DB. Population structure in the Mediterranean basin: a Y chromosome perspective. Ann Hum Genet. 2006;70:207–225. doi: 10.1111/j.1529-8817.2005.00224.x. [PubMed] [Cross Ref]
  • Zalloua PA, Platt DE, El Sibai M, Khalife J, Makhoul N, Haber M, Xue Y, Izaabel H, Bosch E, Adams SM, Arroyo E, López-Parra AM, Aler M, Picornell A, Ramon M, Jobling MA, Comas D, Bertranpetit J, Wells RS, Tyler-Smith C. Genographic Consortium. Identifying genetic traces of historical expansions: Phoenician footprints in the Mediterranean. Am J Hum Genet. 2008;83:633–642. doi: 10.1016/j.ajhg.2008.10.012. [PubMed] [Cross Ref]
  • Capelli C, Brisighelli F, Scarnicci F, Arredi B, Caglia' A, Vetrugno G, Tofanelli S, Onofri V, Tagliabracci A, Paoli G, Pascali VL. Y chromosome genetic variation in the Italian peninsula is clinal and supports an admixture model for the Mesolithic-Neolithic encounter. Mol Phylogenet Evol. 2007;44:228–239. doi: 10.1016/j.ympev.2006.11.030. [PubMed] [Cross Ref]
  • Onofri V, Alessandrini F, Turchi C, Fraternale B, Buscemi L, Pesaresi M, Tagliabracci A. Y-chromosome genetic structure in sub-Apennine populations of Central Italy by SNP and STR analysis. Int J Legal Med. 2007;121:234–237. doi: 10.1007/s00414-007-0153-y. [PubMed] [Cross Ref]
  • Francalacci P, Morelli L, Underhill PA, Lillie AS, Passarino G, Useli A, Madeddu R, Paoli G, Tofanelli S, Calò CM, Ghiani ME, Varesi L, Memmi M, Vona G, Lin AA, Oefner P, Cavalli-Sforza LL. Peopling of three Mediterranean islands (Corsica, Sardinia, and Sicily) inferred by Y-chromosome biallelic variability. Am J Phys Anthropol. 2003;121:270–279. doi: 10.1002/ajpa.10265. [PubMed] [Cross Ref]
  • Semino O, Passarino G, Oefner PJ, Lin AA, Arbuzova S, Beckman LE, De Benedictis G, Francalacci P, Kouvatsi A, Limborska S, Marcikiae M, Mika A, Mika B, Primorac D, Santachiara-Benerecetti AS, Cavalli-Sforza LL, Underhill PA. The genetic legacy of Paleolithic Homo sapiens sapiens in extant Europeans: a Y chromosome perspective. Science. 2000;290:1155–1159. doi: 10.1126/science.290.5494.1155. [PubMed] [Cross Ref]
  • Wells RS, Yuldasheva N, Ruzibakiev R, Underhill PA, Evseeva I, Blue-Smith J, Jin L, Su B, Pitchappan R, Shanmugalakshmi S, Balakrishnan K, Read M, Pearson NM, Zerjal T, Webster MT, Zholoshvili I, Jamarjashvili E, Gambarov S, Nikbin B, Dostiev A, Aknazarov O, Zalloua P, Tsoy I, Kitaev M, Mirrakhimov M, Chariev A, Bodmer WF. The Eurasian heartland: a continental perspective on Y-chromosome diversity. Proc Nat Acad Sci USA. 2001;98:10244–10249. doi: 10.1073/pnas.171305098. [PubMed] [Cross Ref]
  • Kayser M, Lao O, Anslinger K, Augustin C, Bargel G, Edelmann J, Elias S, Heinrich M, Henke J, Henke L, Hohoff C, Illing A, Jonkisz A, Kuzniar P, Lebioda A, Lessig R, Lewicki S, Maciejewska A, Monies DM, Pawłowski R, Poetsch M, Schmid D, Schmidt U, Schneider PM, Stradmann-Bellinghausen B, Szibor R, Wegener R, Wozniak M, Zoledziewska M, Roewer L, Dobosz T, Ploski R. Significant genetic differentiation between Poland and Germany follows present-day political borders, as revealed by Y-chromosome analysis. Hum Genet. 2005;117:428–443. doi: 10.1007/s00439-005-1333-9. [PubMed] [Cross Ref]
  • Balanovsky O, Rootsi S, Pshenichnov A, Kivisild T, Churnosov M, Evseeva I, Pocheshkhova E, Boldyreva M, Yankovsky N, Balanovska E, Villems R. Two sources of the Russian patrilineal heritage in their Eurasian context. Am J Hum Genet. 2008;82:236–250. doi: 10.1016/j.ajhg.2007.09.019. [PubMed] [Cross Ref]
  • Marjanovic D, Fornarino S, Montagna S, Primorac D, Hadziselimovic R, Vidovic S, Pojskic N, Battaglia V, Achilli A, Drobnic K, Andjelinovic S, Torroni A, Santachiara-Benerecetti AS, Semino O. The peopling of modern Bosnia-Herzegovina: Y-chromosome haplogroups in the three main ethnic groups. Ann Hum Genet. 2005;69:757–763. doi: 10.1111/j.1529-8817.2005.00190.x. [PubMed] [Cross Ref]
  • Bosch E, Calafell F, González-Neira A, Flaiz C, Mateu E, Scheil HG, Huckenbeck W, Efremovska L, Mikerezi I, Xirotiris N, Grasa C, Schmidt H, Comas D. Paternal and maternal lineages in the Balkans show a homogeneous landscape over linguistic barriers, except for the isolated Aromuns. Ann Hum Genet. 2006;70:459–487. doi: 10.1111/j.1469-1809.2005.00251.x. [PubMed] [Cross Ref]
  • Cinnioğlu C, King R, Kivisild T, Kalfoğlu E, Atasoy S, Cavalleri GL, Lillie AS, Roseman CC, Lin AA, Prince K, Oefner PJ, Shen P, Semino O, Cavalli-Sforza LL, Underhill PA. Excavating Y-chromosome haplotype strata in Anatolia. Hum Genet. 2004;114:127–148. doi: 10.1007/s00439-003-1031-4. [PubMed] [Cross Ref]
  • Regueiro M, Cadenas AM, Gayden T, Underhill PA, Herrera RJ. Iran: tricontinental nexus for Y-chromosome driven migration. Hum Hered. 2006;61:132–143. doi: 10.1159/000093774. [PubMed] [Cross Ref]
  • Abu-Amero KK, Hellani A, González AM, Larruga AM, Cabrera VM, Underhill PA. Saudi Arabian Y-Chromosome diversity and its relationship with nearby regions. BMC Genet. 2009;10:59. doi: 10.1186/1471-2156-10-59. [PMC free article] [PubMed] [Cross Ref]
  • Zalloua PA, Xue Y, Khalife J, Makhoul N, Debiane L, Platt DE, Royyuru AK, Herrera RJ, Hernanz DF, Blue-Smith J, Wells RS, Comas D, Bertranpetit J, Tyler-Smith C. Genographic Consortium. Y-chromosomal diversity in Lebanon is structured by recent historical events. Am J Hum Genet. 2008;82:873–882. doi: 10.1016/j.ajhg.2008.01.020. [PMC free article] [PubMed] [Cross Ref]
  • Flores C, Maca-Meyer N, Larruga JM, Cabrera VM, Karadsheh N, Gonzalez AM. Isolates in a corridor of migrations: a high-resolution analysis of Y-chromosome variation in Jordan. J Hum Genet. 2005;50:435–441. doi: 10.1007/s10038-005-0274-4. [PubMed] [Cross Ref]
  • Cadenas AM, Zhivotovsky LA, Cavalli-Sforza LL, Underhill PA, Herrera RJ. Y-chromosome diversity characterizes the Gulf of Oman. Eur J Hum Genet. 2008;16:374–386. doi: 10.1038/sj.ejhg.5201934. [PubMed] [Cross Ref]
  • Luis JR, Rowold DJ, Regueiro M, Caeiro B, Cinnioğlu C, Roseman C, Underhill PA, Cavalli-Sforza LL, Herrera RJ. The Levant versus the Horn of Africa: evidence for bidirectional corridors of human migrations. Am J Hum Genet. 2004;74:532–544. doi: 10.1086/382286. [PubMed] [Cross Ref]
  • Cruciani F, Santolamazza P, Shen P, Macaulay V, Moral P, Olckers A, Modiano D, Holmes S, Destro-Bisol G, Coia V, Wallace DC, Oefner PJ, Torroni A, Cavalli-Sforza LL, Scozzari R, Underhill PA. A back migration from Asia to sub-Saharan Africa is supported by high-resolution analysis of human Y-chromosome haplotypes. Am J Hum Genet. 2002;70:1197–1214. doi: 10.1086/340257. [PubMed] [Cross Ref]
  • Arredi B, Poloni ES, Paracchini S, Zerjal T, Fathallah DM, Makrelouf M, Pascali VL, Novelletto A, Tyler-Smith C. A predominantly neolithic origin for Y-chromosomal DNA variation in North Africa. Am J Hum Genet. 2004;75:338–345. doi: 10.1086/423147. [PubMed] [Cross Ref]
  • Semino O, Santachiara-Benerecetti AS, Falaschi F, Cavalli-Sforza LL, Underhill PA. Ethiopians and Khoisan share the deepest clades of the human Y-chromosome phylogeny. Am J Hum Genet. 2002;70:265–268. doi: 10.1086/338306. [PubMed] [Cross Ref]
  • Lovell A, Moreau C, Yotova V, Xiao F, Bourgeois S, Gehl D, Bertranpetit J, Schurr E, Labuda D. Ethiopia: between Sub-Saharan Africa and western Eurasia. Ann Hum Genet. 2005;69:275–287. doi: 10.1046/J.1469-1809.2005.00152.x. [PubMed] [Cross Ref]
  • Zietkiewicz E, Yotova V, Gehl D, Wambach T, Arrieta I, Batzer M, Cole DE, Hechtman P, Kaplan F, Modiano D, Moisan JP, Michalski R, Labuda D. Haplotypes in the dystrophin DNA segment point to a mosaic origin of modern human diversity. Am J Hum Genet. 2003;73:994–1015. doi: 10.1086/378777. [PubMed] [Cross Ref]
  • Bourgeois S, Yotova V, Wang S, Bourtoumieu S, Moreau C, Michalski R, Moisan JP, Hill K, Hurtado AM, Ruiz-Linares A, Labuda D. X-chromosome lineages and the settlement of the Americas. Am J Phys Anthropol. 2009;140:417–428. doi: 10.1002/ajpa.21084. [PubMed] [Cross Ref]
  • Behar DM, Metspalu E, Kivisild T, Achilli A, Hadid Y, Tzur S, Pereira L, Amorim A, Quintana-Murci L, Majamaa K, Herrnstadt C, Howell N, Balanovsky O, Kutuev I, Pshenichnov A, Gurwitz D, Bonne-Tamir B, Torroni A, Villems R, Skorecki K. The matrilineal ancestry of Ashkenazi Jewry: portrait of a recent founder event. Am J Hum Genet. 2006;78:487–497. doi: 10.1086/500307. [PubMed] [Cross Ref]
  • Behar DM, Metspalu E, Kivisild T, Rosset S, Tzur S, Hadid Y, Yudkovsky G, Rosengarten D, Pereira L, Amorim A, Kutuev I, Gurwitz D, Bonne-Tamir B, Villems R, Skorecki K. Counting the founders: the matrilineal genetic ancestry of the Jewish Diaspora. PLoS One. 2008;3:e2062. doi: 10.1371/journal.pone.0002062. [PMC free article] [PubMed] [Cross Ref]
  • Irwin J, Saunier J, Strouss K, Paintner C, Diegoli T, Sturk K, Kovatsi L, Brandstätter A, Cariolou MA, Parson W, Parsons TJ. Mitochondrial control region sequences from northern Greece and Greek Cypriots. Int J Legal Med. 2008;122:87–89. doi: 10.1007/s00414-007-0173-7. [PubMed] [Cross Ref]
  • Babalini C, Martínez-Labarga C, Tolk HV, Kivisild T, Giampaolo R, Tarsi T, Contini I, Barać L, Janićijević B, Martinović Klarić I, Pericić M, Sujoldzić A, Villems R, Biondi G, Rudan P, Rickards O. The population history of the Croatian linguistic minority of Molise (southern Italy): a maternal view. Eur J Hum Genet. 2005;13:902–912. doi: 10.1038/sj.ejhg.5201439. [PubMed] [Cross Ref]
  • Ottoni C, Martínez-Labarga C, vitelli L, Scano G, Fabrini E, Contini I, Biondi G, Rickards O. Human mitochondrial DNA variation in Southern Italy. Ann Hum Biol. 2009;36:785–811. doi: 10.3109/03014460903198509. [PubMed] [Cross Ref]
  • Poetscha M, Wittigb H, Krause D, Lignitz E. Mitochondrial diversity of a northeast German population sample. Forensic Sci Int. 2003;137:125–132. doi: 10.1016/j.forsciint.2003.06.001. [PubMed] [Cross Ref]
  • Tetzlaff S, Brandstätter A, Wegener R, Parson W, Weirich V. Mitochondrial DNA population data of HVS-I and HVS-II sequences from a northeast German sample. Forensic Sci Int. 2007;172:218–224. doi: 10.1016/j.forsciint.2006.12.016. [PubMed] [Cross Ref]
  • Helgason A, Hickey E, Goodacre S, Bosnes V, Stefánsson K, Ward R, Sykes B. mtDNA and the Islands of the North Atlantic: Estimating the Proportions of Norse and Gaelic Ancestry. Am J Hum Genet. 2001;68:723–737. doi: 10.1086/318785. [PubMed] [Cross Ref]
  • Malyarchuk BA, Grzybowski T, Derenko MV, Czarny J, Woźniak M, Miścicka-Śliwka D. Mitochondrial DNA variability in Poles and Russians. Ann Hum Genet. 2002;66:261–283. doi: 10.1046/j.1469-1809.2002.00116.x. [PubMed] [Cross Ref]

Articles from Biology Direct are provided here courtesy of BioMed Central